Add time:08/11/2019         Source:sciencedirect.com

As part of our exploration for new antifungal agents, substituted 4,5-diphenyl imidazolyl pyrimidine hybrids were synthesized. A series of substituted ethyl 1,2,3,6-tetrahydro-4-methyl-2-oxo/thioxo-6-phenyl-1-(4,5-diphenyl-1-H-imidazol-2-yl) pyrimidine-5-carboxylates have been studied for their binding active sites of cytochrome P450 14α-sterol demethylase CPY51 enzyme. For comparison, the binding behavior of known 14DM selective (Fluconazole) and non-selective (Clotrimazole, Miconazole, Griesofulvin) drugs has also been studied. Synthesized compounds were screened for their in vitro antibacterial activity against Staphylococcus aureus, Salmonella typhi, Pseudomonas aurogenosa and Klebsiella pneumonae and also antifungal activity against the opportunistic pathogens Candida albicans.

We also recommend Trading Suppliers and Manufacturers of ETHYL-4-PHENYL PYRIMIDINE-5-CARBOXYLATE (cas 100724-16-1). Pls Click Website Link as below: cas 100724-16-1 suppliers